Pseudonymous crypto trader Capo of Crypto recently identified an intriguing correlation about the appearance of celebrities in cryptocurrency markets and their connection to cycle tops.
The European Commission has granted exceptional marketing authorization for Biogen's Qalsody (tofersen), the first EU-approved treatment targeting the genetic cause of ALS.
Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly improved progression-free survival in NSCLC patients compared to Keytruda.
Scott Johnsson of Van Buren Capital on Friday highlighted numerous regulatory actions taken by the Biden administration and Democrats, which he claims are stifling the growth of the cryptocurrency industry.
Microsoft-backed OpenAI rival in China attracts $400M investment from Saudi's Prosperity7, underscoring geopolitical implications and challenges for US tech companies.
Flutter Entertainment Plc (NYSE: FLUT) announced CFO's departure & replacement by Rob Coldrake. Shift to US market faces challenges, but reports strong growth in revenue, EBITDA & EPS. FLUT stock down 4% in last 12 months. Investors can access industry through ESPO & HERO ETFs. FLUT down 2.47% premarket at $183.25.